Percutaneous Gelled Alcohol Sclerotherapy for Aggressive Angiomas: Evaluation of Feasibility, Safety, and Efficacy
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
The investigators aimed to evaluate efficacy and safety of a non-surgical protocol treatment combining transarterial embolization and percutaneous radiopaque gelled ethanol (RGE) sclerotherapy in a first procedure, then followed by vertebroplasty in a second procedure, to treat aggressive vertebral hemangioma patients in tertiary hospital. Exclusion criteria were age \<18-years old and any association with neurological deficit.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Every patients treated by gelled alcohol sclerotherapy for aggressive angiomas, in the University Hospital of Saint-Etienne.
Locations
Other Locations
France
CHU de Saint-Etienne
RECRUITING
Saint-priest-en-jarez
Contact Information
Primary
Sylvain GRANGE, MD
sylvain.grange@chu-st-étienne.fr
(0)477829066
Time Frame
Start Date: 2024-06-25
Estimated Completion Date: 2024-12
Participants
Target number of participants: 11
Treatments
Study population
Patients who have undergone percutaneous gel ethanol sclerosis for aggressive bone angioma at Saint-Etienne University Hospital.
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Universitaire de Saint Etienne